Uncovering the Daily Experiences of People Living With Advanced Cancer Using an Experience Sampling Method Questionnaire: Development, Content Validation, and Optimization Study
2024

Developing a Questionnaire to Understand Daily Experiences of People with Advanced Cancer

Sample size: 43 publication 10 minutes Evidence: high

Author Information

Author(s): Cahill Naomi, Low Carissa, Wang Shirlene, Hassan Ahmed, Geeraerts Joran, Pivodic Lara, Rosquin Lise, Naert Eline, Crombez Geert, De Ridder Mark, Van den Block Lieve

Primary Institution: Vrije Universiteit Brussel

Hypothesis

The study aims to develop, content validate, and optimize a digital questionnaire for assessing daily experiences of people living with advanced cancer.

Conclusion

The ESM-AC questionnaire was developed and validated, showing good usability for patients with advanced breast or lung cancer.

Supporting Evidence

  • The ESM-AC questionnaire includes 31 momentary items, 2 morning items, and 7 evening items.
  • Participants rated the digital questionnaire as 'easy to use' with an average score of 4.5 out of 5.
  • The study followed COSMIN and EORTC guidelines for content validation.
  • Participants provided feedback that led to the optimization of the questionnaire items.
  • The study involved 3 rounds of interviews with patients and healthcare professionals.
  • Participants had a mean age of 67.3 years, with a mix of lung and breast cancer diagnoses.
  • The questionnaire aims to assess symptoms, concerns, and well-being in real-time.

Takeaway

Researchers created a new tool to help people with advanced cancer share their daily feelings and experiences, making it easier for doctors to understand their needs.

Methodology

A 3-round mixed methods study involving interviews with patients and healthcare professionals to develop and validate the questionnaire.

Potential Biases

Potential bias due to the relatively high functional status of participants and the exclusion of non-Dutch speakers.

Limitations

The study was limited to Dutch-speaking patients from two hospitals, which may affect generalizability.

Participant Demographics

Participants included 43 patients with stage III or IV lung cancer and stage IV breast cancer, with a mean age of 67.3 years.

Digital Object Identifier (DOI)

10.2196/57510

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication